What You Need to Know About Biden’s Prescription Drug Agenda

<p>The success of COVID vaccine development highlights the importance of private sector innovation. Yet, President Biden and Congress are launching a policy attack that could prevent future medical innovation. These short-sighted efforts to “curb prescription drug costs” focus on expanding federal authority over pharmaceutical access, imposing government price controls, and weakening patent protections. This will result in fewer life-saving drugs and cures being developed, and ultimately do more harm than help.</p><p>Health care policy researchers and health providers won’t want to miss this important conversation on policies that protect access to today’s treatments without sacrificing tomorrow’s cures.</p><br /><hr><p style='color:grey; font-size:0.75em;'> See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for privacy and opt-out information.</p>